This new position paper describes and analyses the current and potential applications and value creation of Generative AI for pharmaceutical companies.
News
The quality of Medical Brand Plans is often sub-optimal due to aweak building process, a lack of...
Brand plans are often of limited value due to a weak development process, insufficient market insights, and...
In this new position paper, we propose a proven and straightforward methodology to help the management of...